Close Menu

NEW YORK (360Dx) – Bio-Techne said today that its fiscal 2019 first quarter revenues rose 13 percent year over year, thanks largely to a 17 percent increase in revenues from its protein science business.

For the three months ended Sept. 30, the firm reported revenues of $163.0 million compared to $144.6 million in Q1 2018, beating the analysts' average estimate of $161.9 million. On an organic basis, revenues grew 10 percent year over year. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.